ethyl marketed brand names meilax ronlax drug benzodiazepine derivative possesses anxiolytic anticonvulsant sedative skeletal muscle relaxant animal studies found low toxicity although rats evidence pulmonary phospholipidosis occurred pulmonary foam cells developing longterm use high elimination halflife mechanism action similar benzodiazepines ethyl loflazepate also produces active metabolite stronger parent ethyl loflazepate designed prodrug descarboxyloflazepate active metabolite active metabolite responsible pharmacological effects rather ethyl main metabolites ethyl loflazepate descarbethoxyloflazepate loflazepate accumulation active metabolites ethyl loflazepate affected kidney failure symptoms overdose ethyl loflazepate include sleepiness agitation ataxia hypotonia may also occur severe cases symptoms occur much frequently severely death therapeutic maintenance doses ethyl loflazepate taken weeks reported elderly patients cause death asphyxia due benzodiazepine high doses antidepressant fluvoxamine may potentiate adverse effects ethyl ethyl loflazeplate commercialized mexico trade name victan officially approved following httpsenwikipediaorgwikiethylloflazepate